MAPT and Alzheimer disease: Mice lacking Il33 gene(Il33−/−) developed AD-likedisease after 60–80 weeks, which was characterized by tau abnormality and aheavy loss of neurons/neurites in the cerebral cortex and hippocampus accompaniedwith cognition/memory impairment.